British journal of neurosurgery · 2026
Moyamoya disease beyond Japan and East Asia.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Birkeland Peter
Аннотация
BACKGROUND: Moyamoya disease (MMD) was first described in Japan and is primarily recognized in East Asia. Although rare, it is increasingly diagnosed in Western countries. A Western phenotype - characterized by a lower risk of hemorrhage - has been proposed in a previous review article in this journal.
OBJECTIVES: This narrative review explores MMD from a Western perspective.
RESULTS: Drawing partly on studies from a Danish MMD cohort, the author suggests that MMD exhibits similar features across different regions. Nordic national registries and well-maintained clinical records provide valuable data for gaining a deeper understanding of this disease.
CONCLUSIONS: In our data, the overall Kaplan-Meier 5-year stroke risk was 10%. We observed a trend toward higher stroke risk in females and in those with angiographic progression.
OBJECTIVES: This narrative review explores MMD from a Western perspective.
RESULTS: Drawing partly on studies from a Danish MMD cohort, the author suggests that MMD exhibits similar features across different regions. Nordic national registries and well-maintained clinical records provide valuable data for gaining a deeper understanding of this disease.
CONCLUSIONS: In our data, the overall Kaplan-Meier 5-year stroke risk was 10%. We observed a trend toward higher stroke risk in females and in those with angiographic progression.